This inventor holds 17 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 10 EPO patents, primarily in Alkyleneamine Chemistry. Top assignee: Nouryon Chemicals International B.v.. Active years: 2020-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2025
Areas of Expertise:
Sure, I can help you with that! Here is the article about inventor Slavisa Jovic:
Title: The Innovative Mind of Inventor Slavisa Jovic
Introduction:
Slavisa Jovic, a distinguished inventor based in Utrecht, Netherlands, is recognized for his remarkable contributions to the field of chemistry and manufacturing processes.
Latest Patents:
With an impressive portfolio of 14 patents, Slavisa Jovic's latest inventions include a groundbreaking process for manufacturing ethyleneamine compounds. This innovative process involves two reaction sequences and has far-reaching implications for the production of ethyleneamines and hydroxyethylethyleneamines.
Career Highlights:
Currently affiliated with Nouryon Chemicals International B.V., Slavisa Jovic continues to spearhead cutting-edge research and development initiatives. His expertise in the chemical industry has been instrumental in shaping the future of manufacturing processes.
Collaborations:
Throughout his illustrious career, Slavisa Jovic has collaborated with notable individuals such as Rens Veneman and Antoon Jacob Berend Ten Kate. Together, they have synergized their talents to drive innovation and bring revolutionary ideas to fruition.
Conclusion:
In conclusion, Slavisa Jovic stands as a beacon of innovation in the realm of chemistry and manufacturing. His relentless pursuit of excellence and his commitment to pushing the boundaries of scientific discovery make him a true pioneer in his field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
